Cyclacel Pharmaceuticals, Inc.Cyclacel Pharmaceuticals, Inc.Cyclacel Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc.

No trades
See on Supercharts
Market capitalization
‪2.58 M‬USD
−27.02USD
‪−22.56 M‬USD
‪420.00 K‬USD
‪1.20 M‬
Beta (1Y)
0.74

About Cyclacel Pharmaceuticals, Inc.

CEO
Spiro Rombotis
Headquarters
Berkeley Heights
Founded
1996
ISIN
US23254L8019
FIGI
BBG000CT3XM2
Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CYCC is 1.85 USD — it has decreased by 5.61% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cyclacel Pharmaceuticals, Inc. stocks are traded under the ticker CYCC.
Cyclacel Pharmaceuticals, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
CYCC stock is 8.29% volatile and has beta coefficient of 0.74. Check out the list of the most volatile stocks — is Cyclacel Pharmaceuticals, Inc. there?
One year price forecast for Cyclacel Pharmaceuticals, Inc. has a max estimate of 11.00 USD and a min estimate of 11.00 USD.
CYCC earnings for the last quarter are −7.35 USD whereas the estimation was −5.45 USD which accounts for −34.86% surprise. Estimated earnings for the next quarter are −5.89 USD. See more details about Cyclacel Pharmaceuticals, Inc. earnings.
Yes, you can track Cyclacel Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
CYCC stock has fallen by 7.50% compared to the previous week, the month change is a 27.17% fall, over the last year Cyclacel Pharmaceuticals, Inc. has showed a 81.59% decrease.
CYCC net income for the last quarter is ‪−5.27 M‬ USD, while the quarter before that showed ‪−6.03 M‬ USD of net income which accounts for 12.62% change. Track more Cyclacel Pharmaceuticals, Inc. financial stats to get the full picture.
Today Cyclacel Pharmaceuticals, Inc. has the market capitalization of ‪2.44 M‬, it has decreased by 0.47% over the last week.
No, CYCC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CYCC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cyclacel Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
CYCC reached its all-time high on Mar 16, 2004 with the price of 2141785.37 USD, and its all-time low was 1.76 USD and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cyclacel Pharmaceuticals, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cyclacel Pharmaceuticals, Inc. stock shows the sell signal. See more of Cyclacel Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Cyclacel Pharmaceuticals, Inc. future price: according to them, CYCC price has a max estimate of 11.00 USD and a min estimate of 11.00 USD. Read a more detailed Cyclacel Pharmaceuticals, Inc. forecast: see what analysts think of Cyclacel Pharmaceuticals, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cyclacel Pharmaceuticals, Inc. EBITDA is ‪−25.82 M‬ USD, and current EBITDA margin is ‪−7.21 K‬%. See more stats in Cyclacel Pharmaceuticals, Inc. financial statements.